You are here

Rykindo

Luye claims its first FDA approval, for bi-weekly schizophrenia drug

Pharmaphorum

Tue, 01/17/23 - 11:04 pm

Luye submits NDA for schizophrenia, bipolar disorder therapy

BioCentury

Sat, 03/30/19 - 01:02 pm

Luye Pharma Group

bipolar disorder